The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of the CDK4/6 inhibitor abemaciclib in patients (pts) with advanced and refractory well‐differentiated gastroenteropancreatic neuroendocrine tumors (GEP NETs).
 
Kit Man Wong
Consulting or Advisory Role - Genentech; HalioDx
Research Funding - Adaptimmune; Astellas Pharma; AstraZeneca; Genentech; Mitsubishi Tanabe Pharma; Pfizer; Replimune; Shanghai Denovo
 
Bojana Irene Askovich
Employment - Seattle Biosoftware (I); Viramabs (I)
Leadership - Seattle Biosoftware (I); Viramabs (I)
Stock and Other Ownership Interests - Seattle Biosoftware (I); Viramabs (I)
Honoraria - Puget Sound Oncology Nursing Society
Consulting or Advisory Role - BRIM Biotechnology; Curio Science
Patents, Royalties, Other Intellectual Property - Viramabs (I)
 
Harini Ramachandran
No Relationships to Disclose
 
Jeniece Hensel
No Relationships to Disclose
 
Susan Ottermiller
No Relationships to Disclose
 
Annie Alidina
No Relationships to Disclose
 
Reina Hibbert
No Relationships to Disclose
 
Andrew L. Coveler
Consulting or Advisory Role - Abbvie; Halozyme; Merrimack; Seagen
Research Funding - AbGenomics International (Inst); Amgen (Inst); Amgen (Inst); Genentech (Inst); Gilead Sciences (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); MedImmune (Inst); Newlink Genetics (Inst); Novocure (Inst); Onconova Therapeutics (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Abbvie; Halozyme
 
John A. Thompson
Consulting or Advisory Role - Academy for Continued Healthcare Learning; Alpine Immune Sciences; BJ Bioscience; Calithera Biosciences; Clinical Care Options/NCCN; Meeting Sites Pro; Neoleukin Therapeutics; Seagen
Research Funding - Admune Therapeutics (Inst); Agensys (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Trillium Therapeutics (Inst); Xencor (Inst)
 
Elena Gabriela Chiorean
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Celgene; Eisai; Five Prime Therapeutics; Halozyme; Ipsen; Legend Biotech; Seagen; Vicus Therapeutics
Research Funding - AADi (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); FibroGen; Halozyme (Inst); Ignyta (Inst); Incyte (Inst); Lilly (Inst); MacroGenics (Inst); Merck (Inst); Rafael Pharmaceuticals (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Legend Biotech; Seagen